Become an investor

BCAL Diagnostics (ASX: BDX) is commercialising a next-generation, patient-friendly diagnostic technology to assist in more effective diagnosis of breast cancer.
This page is intended to provide details about research and development for potential investors, commercial and distribution partners.

ASX Announcements

Read our latest shareholder announcements
NameDateSource
Results of meeting15/07/2024Download
BCAL to Present at Bioshares Biotech Summit - Presentation12/07/2024Download
Change is substantial holding21/06/2024Download
Change of Director's Interest Notice17/06/2024Download
Letter to Shareholders re General Meeting 15 July 202413/06/2024Download
Notice of General Meeting/Proxy Form13/06/2024Download
Cleansing Notice11/06/2024Download
Application for quotation of securities - BDX11/06/2024Download
Reinstatement to quotation03/06/2024Download
Proposed issues of securities03/06/2024Download
BCAL receive firm commitment to raise03/06/2024Download
Suspension from quotation31/05/2024Download
Response to price query30/05/2024Download
Trading Halt29/05/2024Download
Pause in Trading29/05/2024Download
Company presentation - investor insights02/05/2024Download
Change in substantial holding01/05/2024Download
4C Quarterly Activities26/04/2024Download
Initial Directors Notice03/04/2024Download
Ceasing to be a substantial shareholder03/04/2024Download
Trademark announcement02/04/2024Download
Change in substantial holding27/03/2024Download
Corporate Presentation06/03/2024Download
Appointment of Strategic CEO to Lead Commercial Launch06/03/2024Download
Final Directors Notice04/03/2024Download
Initial Directors Notice04/03/2024Download
BCAL to host Investor webcast01/03/2024Download
Cleansing notice28/02/2024Download
BCAL Strengthens Board with Appointment of Commercial NED29/02/2024Download
Quarterly Activities/Appendix 4C Cash Flow Report30/01/2024Download
Collaboration with KIMS & Indo-American Hospitals Hyderabad29/11/2023Download
BCAL Files Further Foundational Patent Application06/11/2023Download
Quarterly Activities/Appendix 4C Cash Flow Report31/10/2023Download
BCAL Locks Down Crucial Breast Cancer Signature11/09/2023Download
Shane Ryan Appointed Chief Operating Officer04/09/2023Download
Cleansing Notice01/09/2023Download
Application for quotation of securities - BDX01/09/2023Download
Preliminary Final Report30/08/2023Download
Share Purchase Plan Offer Booklet30/08/2023Download
Proposed issue of securities - BDX29/08/2023Download
$2.4m Capital Raise to Further BREASTEST Commercialisation28/08/2023Download
Investor Presentation24/08/2023Download
ASX Announcement - Trading Halt04/08/2023Download
BCAL Investor Education Update & Webinar08/08/2023Download
Breakthrough Results a Major Step Towards Commercialisation02/08/2023Download
ASX Annoucement28/07/2023Download
ASX Annoucement28/07/2023Download
Quarterly Activities/Appendix 4C Cash Flow Report27/07/2023Download
Shareholder Newsletter20/07/2023Download
ASX Annoucement30/06/2023Download
ASX Annoucements30/06/2023Download
BCAL appoints David Darling as an advisor16/05/2023Download
ASX Annoucement11/05/2023Download
ASX Annoucement03/05/2023Download
BCAL Opens Development & Clinical Service Laboratory03/05/2023Download
ASX Annoucement24/04/2023Download
ASX Annoucement16/01/2023Download
Recent Analysis Significantly Improves Commercial Prospects07/02/2022Download
Establishment of Development & Clinical Services Laboratory05/10/2022Download
BCAL Enters US Product Development Agreement with Precion28/06/2022Download
Shareholder Newsletter15/11/2022Download
Dr John Hurrell Appointed Chief Executive Officer11/01/2022Download
Notice of Annual General Meeting and Explanatory Statement21/10/2021Download
Australian Clinical Studies Launched03/09/2021Download
Market Update17/08/2021Download
Becoming a substantial holder22/07/2021Download
BCAL Diagnostics to list after raising $10m in IPO21/07/2021Download

An effective and accurate blood test should increase the screening detection rate and reduce mortality Lipidomic signature from plasma to detect localised breast cancer 

A/Prof. Gillian Lamoury, BMed FRANZCR, Radiation Oncologist
Sign-Up To Receive The Latest Updates
2024 © BCAL Diagnostics
Privacy Policy
Terms & Conditions
Made by Eightball Media
crossmenu